GB0220212D0 - Vaccine - Google Patents

Vaccine

Info

Publication number
GB0220212D0
GB0220212D0 GB0220212A GB0220212A GB0220212D0 GB 0220212 D0 GB0220212 D0 GB 0220212D0 GB 0220212 A GB0220212 A GB 0220212A GB 0220212 A GB0220212 A GB 0220212A GB 0220212 D0 GB0220212 D0 GB 0220212D0
Authority
GB
United Kingdom
Prior art keywords
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0220212A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0220212A priority Critical patent/GB0220212D0/en
Publication of GB0220212D0 publication Critical patent/GB0220212D0/en
Priority to CA002496409A priority patent/CA2496409A1/en
Priority to US10/526,060 priority patent/US20060147417A1/en
Priority to PCT/GB2003/003703 priority patent/WO2004019974A2/en
Priority to AU2003259358A priority patent/AU2003259358A1/en
Priority to EP03791019A priority patent/EP1532172A2/en
Priority to ARP030103127A priority patent/AR041086A1/en
Priority to TW092123745A priority patent/TW200407162A/en
Priority to JP2004532284A priority patent/JP2006503017A/en
Ceased legal-status Critical Current

Links

GB0220212A 2002-08-30 2002-08-30 Vaccine Ceased GB0220212D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB0220212A GB0220212D0 (en) 2002-08-30 2002-08-30 Vaccine
CA002496409A CA2496409A1 (en) 2002-08-30 2003-08-28 Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use
US10/526,060 US20060147417A1 (en) 2002-08-30 2003-08-28 Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use
PCT/GB2003/003703 WO2004019974A2 (en) 2002-08-30 2003-08-28 Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use
AU2003259358A AU2003259358A1 (en) 2002-08-30 2003-08-28 Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use
EP03791019A EP1532172A2 (en) 2002-08-30 2003-08-28 Immunogenic composition comprising an il-13 element and t cell epitopes, and itstherapeutic use
ARP030103127A AR041086A1 (en) 2002-08-30 2003-08-28 VACCINE
TW092123745A TW200407162A (en) 2002-08-30 2003-08-28 Vaccine
JP2004532284A JP2006503017A (en) 2002-08-30 2003-08-28 Immunogenic composition comprising IL-13 element and T cell epitope and therapeutic use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0220212A GB0220212D0 (en) 2002-08-30 2002-08-30 Vaccine

Publications (1)

Publication Number Publication Date
GB0220212D0 true GB0220212D0 (en) 2002-10-09

Family

ID=9943248

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0220212A Ceased GB0220212D0 (en) 2002-08-30 2002-08-30 Vaccine

Country Status (1)

Country Link
GB (1) GB0220212D0 (en)

Similar Documents

Publication Publication Date Title
GB0213622D0 (en) Vaccine Corporation
GB0202901D0 (en) Novel vaccine
GB0226722D0 (en) Vaccine
IL173921A0 (en) Vaccine
GB0329146D0 (en) Vaccine
GB0225788D0 (en) Vaccine
AU2003285320A8 (en) Vaccine
GB0212046D0 (en) Vaccines
GB0228715D0 (en) Vaccine
GB0218921D0 (en) Novel vaccine
GB0305794D0 (en) Vaccine
GB0209878D0 (en) Vaccine
GB0330079D0 (en) Vaccine
PL376534A1 (en) Vaccine
GB0305793D0 (en) Vaccine
GB0212036D0 (en) Vaccines
GB0206595D0 (en) Vaccine
IL156434A0 (en) Vaccine
GB0223355D0 (en) Vaccine
GB0226179D0 (en) Vaccine
GB0228714D0 (en) Vaccine
GB0229594D0 (en) Vaccine
GB0212606D0 (en) Vaccine
GB0209724D0 (en) Vaccine
GB0218036D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)